[go: up one dir, main page]

ATE111485T1 - Peptidbehandlung von hartnäckigen infektionskrankheiten. - Google Patents

Peptidbehandlung von hartnäckigen infektionskrankheiten.

Info

Publication number
ATE111485T1
ATE111485T1 AT89301259T AT89301259T ATE111485T1 AT E111485 T1 ATE111485 T1 AT E111485T1 AT 89301259 T AT89301259 T AT 89301259T AT 89301259 T AT89301259 T AT 89301259T AT E111485 T1 ATE111485 T1 AT E111485T1
Authority
AT
Austria
Prior art keywords
infectious diseases
peptide treatment
persistent infectious
peptide compound
host
Prior art date
Application number
AT89301259T
Other languages
English (en)
Inventor
Malcolm L Gefter
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Application granted granted Critical
Publication of ATE111485T1 publication Critical patent/ATE111485T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89301259T 1988-02-10 1989-02-09 Peptidbehandlung von hartnäckigen infektionskrankheiten. ATE111485T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15486288A 1988-02-10 1988-02-10

Publications (1)

Publication Number Publication Date
ATE111485T1 true ATE111485T1 (de) 1994-09-15

Family

ID=22553124

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301259T ATE111485T1 (de) 1988-02-10 1989-02-09 Peptidbehandlung von hartnäckigen infektionskrankheiten.

Country Status (4)

Country Link
EP (1) EP0328390B1 (de)
JP (1) JPH01301699A (de)
AT (1) ATE111485T1 (de)
DE (1) DE68918127D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2650954B1 (fr) * 1989-08-18 1992-02-28 Pasteur Institut Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida
US5688914A (en) * 1989-08-18 1997-11-18 Institut Pasteur Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
US6080846A (en) * 1989-08-18 2000-06-27 Institut Pasteur Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
CA2821995C (en) * 2011-01-06 2019-02-12 Bionor Immuno As Monomeric and multimeric peptides immunogenic against hiv

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS256960B1 (en) * 1985-11-16 1988-04-15 Viktor Krchnak Peptides with properties of antigenic determinants and method of their production
JPS63502904A (ja) * 1986-03-24 1988-10-27 オ−ソ・フア−マシユ−チカル・コ−ポレ−シヨン 合成ｈｔｌｖ−３ペプチド、その組成物及び用途
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
DE68918127D1 (de) 1994-10-20
EP0328390A2 (de) 1989-08-16
EP0328390B1 (de) 1994-09-14
JPH01301699A (ja) 1989-12-05
EP0328390A3 (en) 1990-10-31

Similar Documents

Publication Publication Date Title
EP0330359A3 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
DE3855869D1 (de) Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
EP0726758A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
ATE101648T1 (de) Expression eines tumorspezifischen antigens eines rekombinanten virusvektors sowie dessen anwendung zur versorgenden oder heilenden behandlung des entsprechenden tumors.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
DK0499923T3 (da) Dentaladhæsiv
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
ATE103294T1 (de) Peptidfragmente von hiv.
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ATE122100T1 (de) Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen.
DE3854857D1 (de) Verhütung und behandlung einer retrovirenkrankheit
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
ATE115861T1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
IT8349430A0 (it) Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici
CA2156416A1 (en) Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties